Insulin-Secreting Cells from Human Eyelid-Derived Stem Cells Alleviate Type I Diabetes in Immunocompetent Mice
- 14 May 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 27 (8) , 1999-2008
Abstract
Various attempts have been made to develop stem cell-based therapy to alleviate type I diabetes using animal models. However, it has been a question whether human insulin produced from explanted cells is solely responsible for the normoglycemia of diabetic animals. In this study, we isolated neural crest-like stem cells from the human eyelid fat and examined their therapeutic potentials for diabetes. The human eyelid adipose-derived stem cells (HEACs) displayed characteristics of neural crest cells. Using a two-step culture condition combined with nicotinamide, activin, and/or GLP-1, we differentiated HEACs into insulin-secreting cells and examined in vivo effects of differentiated cells by transplantation experiments. Following differentiation in vitro, HEACs released insulin and c-peptide in a glucose-dependent manner. Upon their transplantation under kidney capsules of streptozotocin-treated immunocompetent mice, we observed normalization of hyperglycemia in 10 of 20 recipient mice until sacrifice after 2 months. Only the human, but not the mouse, insulin and c-peptide were detected in the blood of recipient mice. Removal of the kidneys transplanted with HEACs resulted in a sharp increase of blood glucose level. Removed kidney tissues showed distinct expression of various human genes including insulin, and colocalization of the human insulin and the human nuclear protein in many cells. However, they showed diminished or null expression of some immune-related genes. In conclusion, human insulin alone produced from eyelid-derived stem cells following differentiation into insulin-secreting cells and transplantation could normalize type I diabetes in mice. Disclosure of potential conflicts of interest is found at the end of this article.Keywords
Funding Information
- 2008 Seoul Women's University
- Korean Science and Engineering Foundation
- Korean government (R01-2006-000-10501-0)
This publication has 50 references indexed in Scilit:
- Human neural crest cells display molecular and phenotypic hallmarks of stem cellsHuman Molecular Genetics, 2008
- The Neuro-Glial Properties of Adipose-Derived Adult Stromal (ADAS) Cells Are Not Regulated by Notch 1 and Are Not Derived from Neural Crest LineagePLOS ONE, 2008
- Islet-Like Clusters Derived from Mesenchymal Stem Cells in Wharton's Jelly of the Human Umbilical Cord for Transplantation to Control Type 1 DiabetesPLOS ONE, 2008
- Placenta-derived multipotent stem cells induced to differentiate into insulin-positive cellsBiochemical and Biophysical Research Communications, 2007
- Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/ scid miceProceedings of the National Academy of Sciences, 2006
- Production of pancreatic hormone–expressing endocrine cells from human embryonic stem cellsNature Biotechnology, 2006
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Differentiation of Insulin-Producing Cells from Human Neural Progenitor CellsPLOS Medicine, 2005
- Pancreatic organogenesis — developmental mechanisms and implications for therapyNature Reviews Genetics, 2002
- Neurogenic differentiation of murine and human adipose-derived stromal cellsBiochemical and Biophysical Research Communications, 2002